| ²é¿´: 285 | »Ø¸´: 11 | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßzfbg½«ÔùËÍÄú 20 ¸ö½ð±Ò | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
zfbgÌú³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
²Â²ÂÕâÊÇÎÄÏ×»¹ÊÇÊ飡
|
|
|
¾ÍÕâô¶àÐÅÏ¢ £¬²»ÖªµÀÊÇÎÄÏ×»¹ÊÇÒ»±¾Êé £¬Ï£ÍûÅ£È˰ïÎÒ¿´¿´£¡Ëµ³öµãÃŵÀ¸ø5¸ö½ð±Ò£¬²é³öÀ´¸ø20¸ö£¡½ð±Ò²»ÖØÒª£¬ÖúÈËΪÀÖ£¡ Ï£Íû°ßÖñ·ÅÐÐÒ»¶Îʱ¼ä£¡Ð»Ð»ÁË£¡ Antidiabetic Drugs, HPLC/TLC Determination of Authors: A. Gumieniczek a; H. Hopka a a; A. Berecka a Affiliation: a Department of Medicinal Chemistry, Medical University. Lublin. Poland DOI: 10.1081/E-ECHR-120042796 Editor: Published in: Encyclopedia of Chromatography Published on: 27 March 2006 Subject: Analytical Chemistry; Formats available: HTML (English) : PDF (English) Purchase Section: US$12.50 - buy now add to cart ¡¤ Sign In Abstract A review of some chromatographic methods for determination of new oral antidiabetic drugs is presented: gliclazide, glimepiride, and glipizide from sulfonylureas; nateglinide and repaglinide from glinides; and pioglitazone and rosiglitazone from glitazones. This entry describes the selected methods for the analysis of these important drugs in pharmaceuticals and in biological materials. Two chromatographic techniques [High-performance liquid chromatography (HPLC), Thin-layer chromatography (TLC)] and various pretreatment modes are described. Sensitivities, linearities, and specificities of the presented methods are compared. The selected methods for determination of potential impurities in bulk drug substances and metabolites of the drugs in biological samples are described. Stability data concerning the mentioned drugs are also presented. Finally, suitable methods for separation of the drugs as well as their isomers (enantiomers and diastereoisomers) are presented. Keywords: Antidiabetic drugs; HPLC; TLC; Separation view references (25) |
» ²ÂÄãϲ»¶
²ÄÁÏÇóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó×Ü·Ö298·Ö£¬Ç°Èý¿Æ223·Ö
ÒѾÓÐ5È˻ظ´
085600 286·Ö ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
086502»¯Ñ§¹¤³Ì342Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏÇóµ÷¼ÁÒ»Ö¾Ô¸¹þ¹¤´ó324
ÒѾÓÐ7È˻ظ´
328Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
340Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Çóµ÷¼ÁÍÆ¼ö ²ÄÁÏ 304
ÒѾÓÐ15È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
331»·¾³¿ÆÑ§Ó빤³ÌÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´

maxuedong
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
Сľ³æÖÕÉí¹ËÎÊ
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 21195.5
- ºì»¨: 2
- Ìû×Ó: 2248
- ÔÚÏß: 215.2Сʱ
- ³æºÅ: 158820
- ×¢²á: 2006-01-07
- ÐÔ±ð: GG
- רҵ: É«Æ×·ÖÎö

6Â¥2007-07-13 08:54:05
hljbhs
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 7114.9
- Ìû×Ó: 1534
- ÔÚÏß: 12.4Сʱ
- ³æºÅ: 392491
- ×¢²á: 2007-06-04
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯ¹¤ÓëʳƷ»¯¹¤

2Â¥2007-07-12 21:22:49
èÉÀÇ
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2727.5
- Ìû×Ó: 191
- ÔÚÏß: 24.4Сʱ
- ³æºÅ: 420172
- ×¢²á: 2007-07-09
- ÐÔ±ð: GG
- רҵ: Ó¦ÓÃÓлú»¯Ñ§
3Â¥2007-07-13 08:44:21
sunjingxin66
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1524.9
- Ìû×Ó: 442
- ÔÚÏß: 11.1Сʱ
- ³æºÅ: 315610
- ×¢²á: 2007-03-03
- ÐÔ±ð: MM
- רҵ: ÖÆÒ©
4Â¥2007-07-13 08:47:20














»Ø¸´´ËÂ¥